# Curia Bio Inc.

Canonical: https://abierto.us/vendors/curia-bio-inc-pw5lpredn9n5

- UEI: PW5LPREDN9N5
- CAGE: 9TMX2
- Location: Belmont, CA
- Awards in window: 3 (4 transactions), $93,650 obligated, August 5, 2024 to June 25, 2026

## Awarding agencies

- Department of Veterans Affairs: 1 awards, $61,550
- National Institutes of Health: 2 awards, $32,100

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $61,550
- 541380 Testing Laboratories and Services: $32,100

## Competition

- Competed Under SAP: 1 awards
- Not Competed Under SAP: 1 awards
- Full and Open Competition: 1 awards

## Solicitations won

- Material Generation and Molecular Evaluation of 3 Antibodies R&D Services RFQ (36C26025Q0592). https://abierto.us/opportunities/36c26025q0592
- PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers, Preclinical Services for cGMP Biopharmaceutical Product Development and Manufacturing, and Toxicology and Pharmacology Testing (75N91024D00008), $149,995,000. https://abierto.us/opportunities/75n91024d00008

## Largest awards

- 36C26025P1064 (purchase order): $61,550, 260-Network Contract Office 20. Material Generation and Molecular Evaluation Contract. https://www.usaspending.gov/award/CONT_AWD_36C26025P1064_3600_-NONE-_-NONE-/
- 75N93024P00925 (purchase order): $32,100, National Institutes of Health Niaid. Sample Purification Services Relating to Denv and Zikv Viruses. https://www.usaspending.gov/award/CONT_AWD_75N93024P00925_7529_-NONE-_-NONE-/
- 75N91024D00008: $0, NIH NCI. Prevent Cancer Preclinical Drug Development Program: CGMP. https://www.usaspending.gov/award/CONT_IDV_75N91024D00008_7529/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/curia-bio-inc-pw5lpredn9n5.